Unknown

Dataset Information

0

Anti-IL-5 therapies for chronic obstructive pulmonary disease.


ABSTRACT:

SUBMITTER: Donovan T 

PROVIDER: S-EPMC8106745 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-IL-5 therapies for chronic obstructive pulmonary disease.

Donovan Tim T   Milan Stephen J SJ   Wang Ran R   Banchoff Emma E   Bradley Patrick P   Crossingham Iain I  

The Cochrane database of systematic reviews 20201208


<h4>Background</h4>Exacerbations of chronic obstructive pulmonary disease (COPD) are a major cause of hospital admissions, disease-related morbidity and mortality. COPD is a heterogeneous disease with distinct inflammatory phenotypes, including eosinophilia, which may drive acute exacerbations in a subgroup of patients. Monoclonal antibodies targeting interleukin 5 (IL-5) or its receptor (IL-5R) have a role in the care of people with severe eosinophilic asthma, and may similarly provide therapeu  ...[more]